CIRINA
Cirina is developing innovative blood-plasma tests to detect deadly diseases at their earliest stages when curative treatments are most viable. The company is driven by the passion and life-long work of Co-founder and plasma nucleic acid pioneer, Dennis Lo, the first scientist to discover the presence of fetal DNA in a pregnant motherโs blood-plasma. Headquartered in South San Francisco, Calif., Cirina is currently actively recruiting top scientific and business talent to join its quest to detect devastating diseases like cancer at their earliest stages and empower people to take action. For more information, please visit http://cirinalabs.com.
CIRINA
Industry:
Biopharma Biotechnology Clinical Trials Health Care Medical Medical Device
Founded:
2014-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.grail.com
Total Employee:
11+
Status:
Active
Contact:
415) 722-2129
Email Addresses:
[email protected]
Total Funding:
12 M USD
Technology used in webpage:
SPF IPv6 Google Apps For Business Google Google DNS Google Domains Google Cloud DNS
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Current Employees Featured
Founder
Investors List
Decheng Capital
Decheng Capital investment in Series A - Cirina
Official Site Inspections
http://www.grail.com
- Host name: server-3-171-76-32.iad89.r.cloudfront.net
- IP address: 3.171.76.32
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Cirina"
Who We Are - GRAIL
We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we โฆSee details»
Grail - Crunchbase Company Profile & Funding
Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in โฆSee details»
Grail (company) - Wikipedia
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California. It was previously a subsidiary of Illumina started as a startup seeking to develop an early cancer screening test for people who do not have symptoms. Grail was spun-out from Illumina on June 24, 2024. Their liquid biopsy (also called multi-cancer early detection test ) was launcheโฆSee details»
GRAIL Information - RocketReach
GRAIL is headquartered in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and โฆSee details»
GRAIL, Inc. (GRAL) Company Profile & Facts - Yahoo Finance
Description . GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals โฆSee details»
GRAIL, Inc. (GRAL) Company Profile & Facts - Yahoo Finance
See the company profile for GRAIL, Inc. (GRAL) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives โฆSee details»
Investor Relations - GRAIL, Inc.
GRAIL has made significant investments over time in technology, growth, and scalability, and we remain focused on our vision of multi-cancer early detection at the population level." Bob Ragusa. CEO. News Releases. All News Releases. โฆSee details»
GRAIL, Inc. (GRAL) Company Profile & Overview - Stock โฆ
5 days ago GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a โฆSee details»
Environmental, Social and Governance - GRAIL, Inc.
GRAIL is focused on solving one of medicineโs biggest healthcare challenges and pursuing a better way to help address the enormous toll that cancer has on patients, their families and society as a whole. ... (DEI) within our organization โฆSee details»
Home - The Grail in the USA
The Grail in the US is a movement where all members are encouraged to advance our shared vision in the manner that best befits their interests, abilities and the needs of their community. We are individual threads that together โฆSee details»
GRAIL, Inc - amga.org
If you are an organization that supports healthcare provider organizations, you can join as a Corporate Partner. Learn More. ... GRAIL is focused on alleviating the global burden of cancer โฆSee details»
GRAIL Reports Second Quarter 2024 Financial Results and โฆ
Jul 2, 2023 Second Quarter Revenue Grew 43% Year-Over-Year to $32.0 Million. Portfolio Prioritization and Corporate Restructure Extends Cash Runway into 2028. MENLO PARK, โฆSee details»
GRAIL - Org chart - The Org
Explore GRAIL's organizational chart. Discover current team members including executives, board members, and advisors.See details»
The Grail Foundation of America
The Grail Foundation of America is a tax exempt not-for-profit organization which facilitates Grail activities within the USA. Founded in 1977, it acts as legal entity and asset holder for the Grail โฆSee details»
Working At GRAIL: Company Overview and Culture - Zippia
Mar 14, 2024 We calculated GRAIL's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of GRAIL's workforce. GRAIL has 50 โฆSee details»
Reflections on 2023 - GRAIL
Jan 5, 2024 2023 was an exciting year for GRAIL. We are seeing continued strong early adoption of Galleriโ, our multi-cancer early detection (MCED) blood test, surpassing 150,000 โฆSee details»
Grail CEO predicts โtransformativeโ 2024 amid Illumina split
Dec 19, 2023 Dive Brief: Grail has detailed its goals for 2024 after Illumina said that it will finally give up its fight with regulators to retain control of the liquid biopsy test maker it acquired two โฆSee details»
GRAIL - Overview, News & Similar companies | ZoomInfo.com
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology Data Support Clinical Performance of Galleri to Detect โฆSee details»
MedEd - GRAIL
Organization is appropriately firewalled from any affiliated sister or parent organization that provides strategy, marketing, or commercial services to GRAIL and its partners. Organization โฆSee details»